TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Venus Concept devices for feminine health will enable you to provide a variety of internal and external treatments that address a range of conditions affecting vaginal health, such as vaginal atrophy, dryness, discomfort, and laxity. Treatments are non-surgical and do not require hormonal intervention, making them the ideal choice for providers and patients.
Every woman’s body goes through different changes over the years, and because no two women are the same, each patient will have different needs when it comes to feminine health treatments. Our devices are powered by advanced radio frequency technology to provide safe and comfortable treatments that can be tailored to suit each patient’s individual circumstances. Click on a product below to learn more.
The most versatile multi-treatment platform to address the most in-demand aesthetic procedures without surgery or downtime. It integrates three different technologies in one workstation.
The highly advanced device that most effectively resolves challenging face and body aesthetic needs, such as non-surgical cellulite reduction and wrinkle reduction. Treatments have no downtime and use technology that is safe for all skin types.
The easiest-to-use anti-aging system with advanced safety features for non-invasive wrinkle reduction which leads to tightening of the skin with no downtime.
The most cost-effective dermal rejuvenation solution that will make your aesthetic treatments more profitable. Venus Glow™ provides instant results for all skin types.
Powerful skin care essentials with a range of highly active ingredients, including growth factors from stem cells. Venus Skin™ products are clinically proven to deliver visible results and have been formulated to complement Venus Concept treatments.
A unique multi-treatment platform for feminine health, designed with three applicators to address internal vaginal health restoration, labia skin tightening, and mons pubis reduction.
To book a consultation or a demo, please contact us by clicking the button below and a representative will reach out to you directly.
For more information call: (888) 907-0115 // info@venusconcept.com // 1880 N Commerce Parkway, Suite 2, Weston, FL, 33326 United States
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite.
Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.
Venus Velocity™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae, for all Fitzpatrick skin types.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Freeze Plus™ is a non-invasive device cleared by the FDA for use in dermatologic and general surgical procedures for females for the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. The treatment of these conditions will lead to the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Epileve™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs
re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other country/regions and language options, please click the button below.
Click HereAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here